New and updated GLP-1 and metabolic medicine pages on ContentLora.https://contentlora.com/enhttps://contentlora.com/wiki/cagrisema/https://contentlora.com/wiki/cagrisema/CagriSema combines the amylin analogue cagrilintide with semaglutide. Novo Nordisk's REDEFINE results, the miss against tirzepatide and its FDA review.Sat, 10 Oct 2026 00:00:00 GMTWikimetabolic-medicinehealthlife-scienceshttps://contentlora.com/wiki/eli-lilly/https://contentlora.com/wiki/eli-lilly/Eli Lilly makes tirzepatide (Mounjaro, Zepbound) and the GLP-1 pill Foundayo, and is developing retatrutide. Its 2026 results, pipeline and pricing.Sat, 10 Oct 2026 00:00:00 GMTWikimetabolic-medicinehealthlife-scienceshttps://contentlora.com/wiki/novo-nordisk/https://contentlora.com/wiki/novo-nordisk/Novo Nordisk is the Danish maker of semaglutide (Ozempic, Wegovy, Wegovy pill). Its GLP-1 history, 2025–2026 results, pipeline and pricing pressures.Sat, 10 Oct 2026 00:00:00 GMTWikimetabolic-medicinehealthlife-scienceshttps://contentlora.com/wiki/orforglipron/https://contentlora.com/wiki/orforglipron/Orforglipron (Foundayo) is Eli Lilly's once-daily small-molecule GLP-1 pill, FDA-approved for weight management in April 2026. Trial data and pricing.Sat, 10 Oct 2026 00:00:00 GMTWikimetabolic-medicinehealthlife-scienceshttps://contentlora.com/wiki/retatrutide/https://contentlora.com/wiki/retatrutide/Retatrutide is Eli Lilly's investigational GIP, GLP-1 and glucagon triple agonist. Phase 2 and TRIUMPH phase 3 results and its 2027 filing plan.Sat, 10 Oct 2026 00:00:00 GMTWikimetabolic-medicinehealthlife-scienceshttps://contentlora.com/wiki/semaglutide/https://contentlora.com/wiki/semaglutide/Semaglutide (Ozempic, Wegovy, Rybelsus, Wegovy pill) is Novo Nordisk's GLP-1 drug. Its trials, approvals, oral forms, prices and patent status in 2026.Sat, 10 Oct 2026 00:00:00 GMTWikimetabolic-medicinehealthlife-scienceshttps://contentlora.com/wiki/tirzepatide/https://contentlora.com/wiki/tirzepatide/Tirzepatide (Mounjaro, Zepbound) is Eli Lilly's dual GIP/GLP-1 agonist. Its trials, approvals, head-to-head data, sales and pricing as of 2026.Sat, 10 Oct 2026 00:00:00 GMTWikimetabolic-medicinehealthlife-scienceshttps://contentlora.com/events/metabolic-medicine-tracker/https://contentlora.com/events/metabolic-medicine-tracker/Live tracker of GLP-1 and obesity-medicine milestones: approvals, pills, triple agonists, outcome trials, Medicare coverage and pricing, 2023–2026.Sat, 10 Oct 2026 00:00:00 GMTDevelopingmetabolic-medicinehealthlife-scienceshttps://contentlora.com/analysis/glp-1-access-and-pricing-debate/https://contentlora.com/analysis/glp-1-access-and-pricing-debate/GLP-1 prices, Medicare's Bridge, negotiated prices, compounding and generics: the evidence on access in 2026 and the competing views on what comes next.Sat, 10 Oct 2026 00:00:00 GMTAnalysismetabolic-medicinehealthpolicyhttps://contentlora.com/analysis/glp-1-long-term-use-debate/https://contentlora.com/analysis/glp-1-long-term-use-debate/What happens when people stop GLP-1 drugs, what is known about muscle, nutrition and rare side effects, and the competing views on long-term use.Sat, 10 Oct 2026 00:00:00 GMTAnalysismetabolic-medicinehealthhttps://contentlora.com/explain/glp-1-outcome-trials-explained/https://contentlora.com/explain/glp-1-outcome-trials-explained/What the big GLP-1 outcome trials (SELECT, FLOW, ESSENCE, SURMOUNT-OSA, SURPASS-CVOT, evoke) found, how to read them, and what regulators approved.Sat, 10 Oct 2026 00:00:00 GMTExplainermetabolic-medicinehealthhttps://contentlora.com/explain/how-glp-1-drugs-work/https://contentlora.com/explain/how-glp-1-drugs-work/How incretin hormones like GLP-1 and GIP control insulin and appetite, and how drug designers stretched them into weekly shots, pills and multi-agonists.Sat, 10 Oct 2026 00:00:00 GMTExplainermetabolic-medicinehealthlife-scienceshttps://contentlora.com/explain/metabolic-medicine/https://contentlora.com/explain/metabolic-medicine/A sourced crash course on GLP-1 drugs: incretin biology, semaglutide, tirzepatide, pills and triple agonists, outcome trials, prices and coverage.Sat, 10 Oct 2026 00:00:00 GMTExplainermetabolic-medicinehealthlife-scienceshttps://contentlora.com/explain/obesity-as-a-disease/https://contentlora.com/explain/obesity-as-a-disease/Why WHO and a Lancet Commission now frame obesity as a chronic disease, what "clinical" versus "preclinical" obesity means, and BMI's limits.Sat, 10 Oct 2026 00:00:00 GMTExplainermetabolic-medicinehealth